Cresilon

New York, NY · Founded 2012 · Privately Held (backing)

Developer of hemostatic products designed to support the natural clotting and promote wound healing. Cresilon is based in New York, NY and was founded in 2012. Its last reported valuation was $340 million in Apr 2024. It has raised $160 million across 8 recorded rounds; the latest was a $29 million early-stage round in Apr 2026.

Last reported valuation
$340.0M
Oct 2026
Priced at
—
Total raised
$159.5M
Last round
Early Stage VC
Apr 2026

Who backs Cresilon?

20 investors
InvestorType
Dorm Room FundOther
First Round CapitalOther
Catalio Capital ManagementVenture capital
NYU Summer Launchpad—
Hammerstone CapitalFamily office
EP Fullerton—
Entrepreneurship Lab Bio & Health Tech NYC—
Future Labs—
Innovating Capital—
Jed Limmer—
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cresilon investors

20 investors are on record for Cresilon, including Dorm Room Fund, First Round Capital, Catalio Capital Management and NYU Summer Launchpad. The early-stage round in Apr 2026 drew 217 investors.

Free account
More of Cresilon with a free account
  • ·The complete investor list: 20 names
  • ·Watch Cresilon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Cresilon. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View